Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $70.31 USD
Change Today +0.19 / 0.27%
Volume 6.4M
MYL On Other Exchanges
As of 2:15 PM 07/6/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Rajiv Malik

President, Executive Director and Member of Science & Technology Committee, Mylan N.V.
AgeTotal Calculated CompensationThis person is connected to 24 board members in 3 different organizations across 5 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Rajiv Malik has been the President at Mylan N.V. since January 1, 2012. Mr. Malik serves as Company Secretary at ANG Auto Ltd. (ANG Industries Ltd.). He served as Senior Vice President, Head of Operations and Head of Business Operations at Advinus Therapeutics Limited. He served as the Chief Operating Officer at Mylan N.V. from July 2009 to December 2012 and as its Executive Vice President from October 2007 to January 1, 2012 and Head of Global Technical Operations ...

Read Full Background

Corporate Headquarters*

Albany Gate
Potters Bar, Hertfordshire EN6 1AG

United Kingdom

Phone: 44 1707 853000
Fax: 44 1707 643148

Board Members Memberships*

Non Executive Director, Chairman of Audit Committee, Member of Executive Committee, Member of Investors Redressal Committee, Member of Investor Grievance Committee and President of Mylan Inc
President, Executive Director and Member of Science & Technology Committee


Master's Degree
Panjab University
Drexel University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$890,385

Stock Options*

Restricted Stock Awards$2,520,003
All Other Compensation$7,284,822
Exercised Options200,000
Exercised Options Value$6,772,847
Exercisable Options285,394
Unexercisable Options1,331,367
Total Value of Options$6,772,847
Total Number of Options1,816,761

Total Compensation*

Total Annual Cash Compensation$10,049,592
Total Short Term Compensation$890,385
Other Long Term Compensation$9,804,825
Total Calculated Compensation$25,164,652
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MYL:US $70.30 USD +0.18


Vincent A. Forlenza Chairman, Chief Executive Officer, President and Chairman of Executive Committee
Becton, Dickinson and Company
Dilip Shantilal Shanghvi Managing Director, Executive Director and Member of Shareholders/Investors Grievance Committee
Sun Pharmaceutical Industries Limited
Joseph C. Papa Chairman, Chief Executive Officer and President
Perrigo Company Public Limited Company
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MYLAN NV, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at